The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosisShow others and affiliations
2019 (English)In: Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, E-ISSN 1099-1557, Vol. 28, no Suppl. 2, p. 371-372Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
John Wiley & Sons, 2019. Vol. 28, no Suppl. 2, p. 371-372
National Category
Public Health, Global Health, Social Medicine and Epidemiology Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:oru:diva-76188ISI: 000481785602248OAI: oai:DiVA.org:oru-76188DiVA, id: diva2:1349835
Conference
35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Pennsylvania Convention Center, Philadelphia, PA, USA, August 24‐28, 2019
Note
Funding Agencies:
Bayer AG
Biogen
Merck KGaA
Novartis Pharma AG
2019-09-102019-09-102019-09-10Bibliographically approved